×

Cramer's Homework: CLMT Doesn't Add Up

6:47 PM ET Fri, 16 Sept 2011

Cramer sharpens his pencil on Calumet Specialty Products and says lackluster growth, plus unsteady cash flow, plus distribution problems, plus a spotty history, equals a stock investors should stay away.